NCT00002412View on ClinicalTrials.gov

A Study of MKC-442 in Combination With Other Anti-HIV Drugs

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Emivirine

DRUG

Hydroxyurea

DRUG

Stavudine

DRUG

Didanosine

Trial Locations (1)

33713

Dr Robert Wallace, St. Petersburg

Sponsors
All Listed Sponsors
lead

Triangle Pharmaceuticals

INDUSTRY